0000899243-19-020491.txt : 20190726
0000899243-19-020491.hdr.sgml : 20190726
20190726212806
ACCESSION NUMBER: 0000899243-19-020491
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190715
FILED AS OF DATE: 20190726
DATE AS OF CHANGE: 20190726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taglietti Marco
CENTRAL INDEX KEY: 0001408870
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16133
FILM NUMBER: 19979214
MAIL ADDRESS:
STREET 1: C/O FOREST LABORATORIES, INC.
STREET 2: 909 THIRD AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DELCATH SYSTEMS, INC.
CENTRAL INDEX KEY: 0000872912
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 061245881
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1633 BROADWAY
STREET 2: SUITE 22C
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (212) 489-2100
MAIL ADDRESS:
STREET 1: 1633 BROADWAY
STREET 2: SUITE 22C
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: DELCATH SYSTEMS INC
DATE OF NAME CHANGE: 19990607
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-15
0
0000872912
DELCATH SYSTEMS, INC.
DCTH
0001408870
Taglietti Marco
C/O DELCATH SYSTEMS, INC.,
1633 BROADWAY, SUITE 22C
NEW YORK
NY
10019
1
0
0
0
Series E Convertible Preferred Stock
0.06
2019-07-15
4
P
0
60
1000.00
A
Common Stock
1000000
60
D
Common Stock Warrant (Right to Buy)
0.06
2019-07-15
4
P
0
1000000
A
Common Stock
1000000
1000000
D
Each share of the Series E Convertible Preferred Stock, par value of $0.01 per share, has a stated value of $1,000 (the "Stated Value") and is convertible at any time at the option of the holder into the number of shares of Delcath common stock determined by dividing the Stated Value by the conversion price of $0.06, subject to certain limitations and adjustments contemplated within the Certificate of Designation.
The purchase was made in a private (PIPE) transaction with the issuer in which the issuer sold Series E Convertible Preferred Stock and warrants. The transactions contemplated by the PIPE transaction were reported on a current report on Form 8-K filed with the SEC by the issuer on each of July 11, 2019 and July 22, 2019.
The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split.
The Series E Convertible Preferred Stock has no expiration date.
/s/ Barbra Keck, attorney-in-fact
2019-07-26